Insider · CIK 0001702447

Patel Samir Rashmikant

Reports to the SEC for 2 companies · TAMPA, FL

sec.gov

Transactions

Companies

Filings

CIK

0001702447

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-05	AKTXAkari Therapeutics PlcA Award	Director	AAward	+2,236 sh	$7.90	+$17.7K	12,102
2026-08-18	AKTXAkari Therapeutics PlcA Award	Director	AAward	+6,300 sh	$7.90	+$49.8K	9,866
2026-08-18	AKTXAkari Therapeutics Plc · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2026-08-18	AKTXAkari Therapeutics Plc · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2026-07-07	AKTXAkari Therapeutics PlcM Exercise/Conversion	Director	MExercise/Conversion	+1,209 sh	$8.00	+$9,672	76,976
2026-07-07	AKTXAkari Therapeutics PlcM Exercise/Conversion	Director	MExercise/Conversion	+15.5K sh	$0.00	+$6.186	92,442
2026-07-07	AKTXAkari Therapeutics PlcM Exercise/Conversion	Director	MExercise/Conversion	+5,799 sh	$0.00	+$2.32	98,241
2026-07-07	AKTXAkari Therapeutics Plc · Pre-Funded Warrant to purchase American Depositary SharesM Exercise/Conversion	Director	MExercise/Conversion	+1,209 sh	$32.00	+$38.7K	0
2026-07-07	AKTXAkari Therapeutics Plc · Pre-Funded Warrant to purchase ADSsM Exercise/Conversion	Director	MExercise/Conversion	+15.5K sh	$16.16	+$250K	0
2026-07-07	AKTXAkari Therapeutics Plc · Pre-Funded Warrant to purchase ADSsM Exercise/Conversion	Director	MExercise/Conversion	+5,799 sh	$16.16	+$93.7K	0
2025-12-16	AKTXAkari Therapeutics Plc · Warrants to purchase American Depositary Shares ("ADRs")P Purchase	Director	PPurchase	+619K sh	—	—	618,658
2025-12-16	AKTXAkari Therapeutics Plc · Pre-Funded Warrants to purchase ADRsP Purchase	Director	PPurchase	+619K sh	$0.40	+$250K	618,658
2025-12-16	AKTXAkari Therapeutics Plc · Warrants to purchase ADRsP Purchase	Director	PPurchase	+232K sh	—	—	231,997
2025-12-16	AKTXAkari Therapeutics Plc · Pre-Funded Warrants to purchase ADRsP Purchase	Director	PPurchase	+232K sh	$0.40	+$93.7K	231,997
2025-03-20	AKTXAkari Therapeutics Plc · Stock Option (Right to Buy)A Award	Director	AAward	+175K sh	—	—	175,000
2025-03-20	AKTXAkari Therapeutics Plc · Stock Option (Right to Buy)A Award	Director	AAward	+225K sh	—	—	225,000
2025-03-06	AKTXAkari Therapeutics PlcA Award	Director	AAward	+406K sh	$1.12	+$455K	3,031,005
2025-03-06	AKTXAkari Therapeutics Plc · Series A Warrants (Right to Buy)A Award	Director	AAward	+406K sh	$1.12	+$455K	406,250
2025-03-06	AKTXAkari Therapeutics Plc · Series B Warrants (Right to Buy)A Award	Director	AAward	+406K sh	$1.12	+$455K	406,250
2025-01-03	AKTXAkari Therapeutics PlcA Award	Director	AAward	+208K sh	$0.00	+$124.8	5,249,511,500
2025-01-03	AKTXAkari Therapeutics Plc · Stock Option (Right to Buy)A Award	Director	AAward	+153M sh	—	—	152,672,000
2024-12-27	AKTXAkari Therapeutics PlcA Award	Director	AAward	+400K sh	$0.00	+$200	5,249,303,500
2024-12-26	AKTXAkari Therapeutics PlcA Award	Director	AAward	+3.2M sh	$0.00	+$1,600	5,248,903,500
2024-12-24	AKTXAkari Therapeutics PlcA Award	Director	AAward	+7.5M sh	$0.00	+$3,750	5,245,703,500
2024-12-23	AKTXAkari Therapeutics PlcA Award	Director	AAward	+1.4M sh	$0.00	+$700	5,238,203,500
2024-12-20	AKTXAkari Therapeutics PlcA Award	Director	AAward	+1.4M sh	$0.00	+$700	5,236,803,500
2024-12-02	AKTXAkari Therapeutics PlcA Award	Director	AAward	+419M sh	$0.00	+$503K	5,235,403,500
2024-12-02	AKTXAkari Therapeutics Plc · Warrants (Right to Buy)A Award	Director	AAward	+419M sh	$0.00	+$503K	419,286,000
2024-11-30	AKTXAkari Therapeutics Plc · Stock Option (Right to Buy)A Award	Director	AAward	+163M sh	—	—	162,604,000
2024-11-14	AKTXAkari Therapeutics PlcA Award	Director	AAward	+1.4B sh	—	—	4,816,117,500
2024-10-31	AKTXAkari Therapeutics Plc · Stock Option (Right to Buy)A Award	Director	AAward	+79.7M sh	—	—	79,684,000
2024-09-30	AKTXAkari Therapeutics Plc · Stock Option (Right to Buy)A Award	Director	AAward	+175M sh	—	—	175,080,000
2024-06-30	AKTXAkari Therapeutics PlcA Award	Director	AAward	+91.4M sh	—	—	91,396,000
2024-05-31	AKTXAkari Therapeutics PlcA Award	Director	AAward	+1.33B sh	$0.00	+$1.19M	3,411,495,500
2024-05-31	AKTXAkari Therapeutics Plc · Warrants (Right to Buy)A Award	Director	AAward	+1.33B sh	$0.00	+$1.19M	1,326,258,000
2021-11-24	CYDYCytoDyn Inc. · Non-qualified Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−225K sh	—	—	0
2021-11-24	CYDYCytoDyn Inc. · Non-qualified Stock OptionA Award	Director	AAward	+93.8K sh	—	—	93,750
2021-11-24	CYDYCytoDyn Inc. · Non-qualified Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−225K sh	—	—	0
2021-11-24	CYDYCytoDyn Inc. · Non-qualified Stock OptionA Award	Director	AAward	+225K sh	—	—	225,000
2021-11-24	CYDYCytoDyn Inc. · Non-qualified Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−12.3K sh	—	—	0
2021-11-24	CYDYCytoDyn Inc. · Non-qualified Stock OptionA Award	Director	AAward	+12.3K sh	—	—	12,329
2021-11-24	CYDYCytoDyn Inc. · Non-qualified Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−225K sh	—	—	0
2021-11-24	CYDYCytoDyn Inc. · Non-qualified Stock OptionA Award	Director	AAward	+113K sh	—	—	112,500
2021-11-24	CYDYCytoDyn Inc. · Non-qualified Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−225K sh	—	—	0
2021-11-24	CYDYCytoDyn Inc. · Non-qualified Stock OptionA Award	Director	AAward	+225K sh	—	—	225,000
2021-11-24	CYDYCytoDyn Inc. · Non-qualified Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−12.3K sh	—	—	0
2021-11-24	CYDYCytoDyn Inc. · Non-qualified Stock OptionA Award	Director	AAward	+12.3K sh	—	—	12,329
2021-10-18	CYDYCytoDyn Inc. · Non-qualified Stock OptionA Award	Director	AAward	+225K sh	—	—	225,000
2020-06-25	CYDYCytoDyn Inc. · Non-qualified Stock OptionA Award	Director	AAward	+225K sh	—	—	225,000
2020-04-17	CYDYCytoDyn Inc. · Stock OptionA Award	Director	AAward	+12.3K sh	$2.25	+$27.7K	12,329

Recent filings

Accepted (ET)
Oct 164
Patel Samir Rashmikant0001493152-26-047453
SEC(opens sec.gov)
Jul 174
Patel Samir Rashmikant0001493152-26-033634
SEC(opens sec.gov)
Dec 184
Patel Samir Rashmikant0001493152-25-028418
SEC(opens sec.gov)
Mar 244
Patel Samir Rashmikant0000950170-25-043938
SEC(opens sec.gov)
Mar 104
Patel Samir Rashmikant0000950170-25-036486
SEC(opens sec.gov)
Jan 74
Patel Samir Rashmikant0000950170-25-002864
SEC(opens sec.gov)

Companies

Address

C/O AKARI THERAPEUTICS PLC 401 EAST JACKSON STREET, SUITE 3300

TAMPA, FL, 33602